SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 85.24+0.5%Feb 4 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (3308)8/5/2015 3:28:29 PM
From: Jibacoa   of 3722
 
Yes, my stop loss order was triggered at 67.24 <g>
I may buy it back at 65.50 or even a little higher, depending on the pattern.<g>

<<"FOVISTA first P3 read out (IF they reported each trial separately) is ~+9 months away">>
That's probably correct. <g>
I always try to base my decisions of buying or selling according to the price actions,
since that's the ultimate opinion of all those involved at any particular time.<g>

However, although the actual results won't be known for some time,
the rumor around is that Fovista will have good results,
and it won't compete directly with Lucentis or Eylea, since it could be used in conjuntion
if it can reduce the amount of changes from fibrosis.<g>

My position on OPHT is a small one. <g>
And I more concerned about the report of OPKO's 2ndQ later today..

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext